Our management team combines expertise in several fields of business development: the structuring and management of innovative companies involving renowned researchers, their development, their access to financing including the public market, their promotion and valorization.
Dany Valiquette Président Glycovax

Founder - President 

20 years of business experience in the structuring and valorisation of innovative companies involving eminent scientists.
DR. René Roy Fondateur, VP recherche Glycovax

René Roy, Ph.D.

Founder, V-P Research
40 years of research experience. 340 scientific articles and 2 books. 4 patents and 2 commercial successes. Several million children saved. Eradication of meningitis in Cuba.
Marc Beausoleil VP Exécutif Glycovax

Marc Beausoleil

Executive VP
20 years of experience in advising inno-vative technology companies. Investment fund manager. Emerging business financing Board Director
Jean-Francois Paquet CFO Glycovax

Jean-François Paquet, M.Sc.

Chief Financial Officer
20 years of experience in business financing. Management and implementation of several business acquisition and restructuring, business and strategic plans.
Serge Moffett Ph.D. Directeur Immunologie Glycovax

Serge Moffett, Ph.D.

Director - Immunology
17 years of pharma industry experience in the development of medicine for therapy and detection of cancers. Postdoctoral fellow in biochemestry. 4 scientific articles and 5 patents.
Dr Daniel Boismenu Ph.D. Administrateur Glycovax

Daniel Boismenu, Ph.D.

V-P Scientific Affairs  
35 years of research experience. 2 postdoctoral fellows in mass spectrometry of pharmaceutical molecules. Co-creator, proteomic platform of Montréal and of Génome Québec.

Tze Shieh Shiao, M.Sc.

Director - Glycochemistry
Expert in the chemistry of dendrimers and synthetic vaccines. Co-author of 200 scientific papers and communications and also a patent on glycoconjugates.

Rabindra Rej, Ph.D.

Rabindra Rej, Ph.D.

Senior Scientist
35 years of research experience. 3 post-doctorates in biopharmaceuticals. 19 years of industry experience. Unique expertise in the establishment of molecular synthesis protocols.